Printed From BioPortfolio.com
Drug combination may boost immunotherapy responses in lung cancer patients
06:02 EST 6 Dec 2017 | ecancermedicalscience
Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime non-small cell lung cancers to respond better to immunotherapy. These so-called epigenetic therapy drugs, used together,...
Original Article: Drug combination may boost immunotherapy responses in lung cancer patients
